The Government Accountability Office (GAO) today released the following reports:

Reports

1.  Brand-Name Prescription Drug Pricing:  Lack of Therapeutically Equivalent 
Drugs and Limited Competition May Contribute to Extraordinary Price Increases.  
GAO-10-201, December 22.
http://www.gao.gov/cgi-bin/getrpt?GAO-10-201
Highlights - http://www.gao.gov/highlights/d10201high.pdf

2.  2009 Tax Filing Season:  IRS Met Many 2009 Goals, but Telephone Access 
Remained Low, and Taxpayer Service and Enforcement Could Be Improved.  
GAO-10-225, December 10.
http://www.gao.gov/cgi-bin/getrpt?GAO-10-225
Highlights - http://www.gao.gov/highlights/d10225high.pdf

3.  Corporate Crime: DOJ Has Taken Steps to Better Track Its Use of Deferred 
and Non-Prosecution Agreements, but Should Evaluate Effectiveness.  GAO-10-110, 
December 18.
http://www.gao.gov/cgi-bin/getrpt?GAO-10-110
Highlights - http://www.gao.gov/highlights/d10110high.pdf

       

You'll find the most up-to-date listing of Reports and Testimonies at 
http://www.gao.gov.

Help with viewing PDF files is available from the "Help" section of 
http://www.gao.gov. 
Check the information in the section titled, "Help with Reading Portable 
Document Format Files" if you have difficulty.

Subscribe to this or other E-mail updates about GAO products at the "E-mail 
Updates" section of http://www.gao.gov.

Remove yourself from this mailing list by sending an E-mail message to: 
[email protected] with the message: unsubscribe daybook in the message 
body.

Information on ordering printed copies at:
http://www.gao.gov/ordering.htm
 
Members of the press may request copies from the Office of Public Affairs, 
202-512-4800.

===========================================================
This list is produced by the Government Accountability Office
to provide daily information about GAO Reports and Testimonies.
Visit GAO on the web at http://www.gao.gov

Reply via email to